High-quality, depth-cue-enhanced lensless holographic near-eye displays via pupil optimization
Optics Letters · 01.11.2025 · 50 (21) · 6811
DOI: 10.1364/ol.569584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Letters, online erschienen am 30.10.2025. Verfasst von Jie Zhou und 5 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Holographic near-eye displays (NEDs) offer a promising pathway toward compact and immersive virtual and augmented reality (VR/AR) systems by enabling natural 3D perception through wavefront reconstruction. Although advances in computational algorithms have improved image quality and real-time performance, practical implementations of holographic NEDs still face challenges in achieving high-quality reconstruction and apparent depth cues without bulky optics. In this Letter, we propose what we believe to be a novel multi-aperture pupil optimization algorithm tailored for lensless holographic NEDs that enhances reconstructed image quality and depth perception. The method is validated through simulations and optical experiments.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, J., Xie, S., Jiang, L., Luo, Y., Wu, Y., & Wang, J. (2025). High-quality, depth-cue-enhanced lensless holographic near-eye displays via pupil optimization. Optics Letters, 50(21), 6811. https://doi.org/10.1364/ol.569584
Vancouver
Zhou J, Xie S, Jiang L, Luo Y, Wu Y, Wang J. High-quality, depth-cue-enhanced lensless holographic near-eye displays via pupil optimization. Optics Letters. 2025;50(21):6811. doi:10.1364/ol.569584
BibTeX
@article{Zhou2025,
author = {Zhou, Jie and Xie, Shuyang and Jiang, Lei and Luo, Yimou and Wu, Yang and Wang, Jun},
title = {High-quality, depth-cue-enhanced lensless holographic near-eye displays via pupil optimization},
journal = {Optics Letters},
year = {2025},
volume = {50},
number = {21},
pages = {6811},
doi = {10.1364/ol.569584}
}
EUVIMED